Stanley N Caroff

Summary

Country: USA

Publications

  1. doi request reprint Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia
    Stanley N Caroff
    Department of Psychiatry, Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 72:295-303. 2011
  2. ncbi request reprint Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol
    Steven L Sayers
    Philadelphia Veterans Affairs Medical Center, University and Woodland Avenues, Philadelphia, PA 19104, USA
    J Nerv Ment Dis 193:379-86. 2005
  3. ncbi request reprint A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation
    Theodore D Satterthwaite
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3535 Market St, 2nd Floor, Philadelphia, PA 19104, USA
    J Clin Psychiatry 69:1869-79. 2008
  4. pmc Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial
    Stanley N Caroff
    Department of Psychiatry, Veterans Affairs Medical Center 116A, University and Woodland Avenues, Philadelphia, PA 19104, USA
    Neurol Clin 29:127-48, viii. 2011
  5. ncbi request reprint Neuroleptic malignant syndrome in elderly patients
    Stanley N Caroff
    Department of Psychiatry, University of Pennsylvania School of Medicine, PA, USA
    Expert Rev Neurother 7:423-31. 2007
  6. doi request reprint A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients
    E Cabrina Campbell
    Philadelphia Veterans Affairs Medical Center and The University of Pennsylvania School of Medicine, VA Medical Center 116A, University and Woodland Aves, Philadelphia, PA 19104, United States
    Prog Neuropsychopharmacol Biol Psychiatry 35:246-51. 2011
  7. ncbi request reprint Movement disorders associated with atypical antipsychotic drugs
    Stanley N Caroff
    Department of Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    J Clin Psychiatry 63:12-9. 2002
  8. ncbi request reprint Neuroleptic malignant syndrome
    Jeffrey R Strawn
    University of Cincinnati, Department of Psychiatry, College of Medicine, Box 670559, Cincinnati, OH 45267 0559, USA
    Am J Psychiatry 164:870-6. 2007
  9. ncbi request reprint Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial
    Stanley N Caroff
    Department of Veterans Affairs Medical Center, University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 68:410-5. 2007
  10. doi request reprint An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method
    Ronald J Gurrera
    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA
    J Clin Psychiatry 72:1222-8. 2011

Detail Information

Publications10

  1. doi request reprint Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia
    Stanley N Caroff
    Department of Psychiatry, Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 72:295-303. 2011
    ..We compared the response to antipsychotic treatment between patients with and without tardive dyskinesia (TD) and examined the course of TD...
  2. ncbi request reprint Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol
    Steven L Sayers
    Philadelphia Veterans Affairs Medical Center, University and Woodland Avenues, Philadelphia, PA 19104, USA
    J Nerv Ment Dis 193:379-86. 2005
    ..Important study limitations include a small sample size and high attrition rates. Larger controlled studies are necessary to determine optimal antipsychotic therapy for patients with schizophrenia and comorbid cocaine abuse...
  3. ncbi request reprint A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation
    Theodore D Satterthwaite
    Department of Psychiatry, University of Pennsylvania School of Medicine, 3535 Market St, 2nd Floor, Philadelphia, PA 19104, USA
    J Clin Psychiatry 69:1869-79. 2008
    ..We examined the evidence for a decreased risk of extrapyramidal symptoms (EPS) with intramuscular second-generation antipsychotics (SGAs) versus intramuscular haloperidol alone or in combination with an anticholinergic agent...
  4. pmc Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial
    Stanley N Caroff
    Department of Psychiatry, Veterans Affairs Medical Center 116A, University and Woodland Avenues, Philadelphia, PA 19104, USA
    Neurol Clin 29:127-48, viii. 2011
    ....
  5. ncbi request reprint Neuroleptic malignant syndrome in elderly patients
    Stanley N Caroff
    Department of Psychiatry, University of Pennsylvania School of Medicine, PA, USA
    Expert Rev Neurother 7:423-31. 2007
    ..To enhance patient safety and clinical vigilance among practitioners, the authors present a clinical overview of neuroleptic malignant syndrome...
  6. doi request reprint A pilot study of antipsychotic prescribing decisions for acutely-Ill hospitalized patients
    E Cabrina Campbell
    Philadelphia Veterans Affairs Medical Center and The University of Pennsylvania School of Medicine, VA Medical Center 116A, University and Woodland Aves, Philadelphia, PA 19104, United States
    Prog Neuropsychopharmacol Biol Psychiatry 35:246-51. 2011
    ..Evidence on antipsychotic prescribing decisions is limited. This pilot study quantified factors considered in choosing an antipsychotic and evaluated the influence of metabolic status on treatment decisions...
  7. ncbi request reprint Movement disorders associated with atypical antipsychotic drugs
    Stanley N Caroff
    Department of Veterans Affairs Medical Center and the University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    J Clin Psychiatry 63:12-9. 2002
    ..Passive resolution of TD may be facilitated in some patients by the use of these agents. Thus, the risk of movement disorders has become only one of several considerations in choosing among antipsychotic drugs...
  8. ncbi request reprint Neuroleptic malignant syndrome
    Jeffrey R Strawn
    University of Cincinnati, Department of Psychiatry, College of Medicine, Box 670559, Cincinnati, OH 45267 0559, USA
    Am J Psychiatry 164:870-6. 2007
  9. ncbi request reprint Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial
    Stanley N Caroff
    Department of Veterans Affairs Medical Center, University of Pennsylvania School of Medicine, Philadelphia, USA
    J Clin Psychiatry 68:410-5. 2007
    ..To test whether cholinesterase inhibitors compensate for diminished cholinergic activity, we conducted a 30-week randomized, double-blind, placebo-controlled crossover trial of galantamine in patients with tardive dyskinesia...
  10. doi request reprint An international consensus study of neuroleptic malignant syndrome diagnostic criteria using the Delphi method
    Ronald J Gurrera
    Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA
    J Clin Psychiatry 72:1222-8. 2011
    ..The purpose of this study was to develop NMS diagnostic criteria reflecting a broad consensus among clinical knowledge experts, represented by an international multispecialty physician panel...